86 related articles for article (PubMed ID: 2591267)
21. [Profile of the complement system in a family with hereditary angioedema].
Rivero S; Guzmán L
Rev Med Chil; 1983 Nov; 111(11):1111-6. PubMed ID: 6431574
[No Abstract] [Full Text] [Related]
22. [Hereditary complement deficiencies].
Fischer E
Hautarzt; 1982 Feb; 33(2):65-72. PubMed ID: 6281215
[TBL] [Abstract][Full Text] [Related]
23. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
Beyer-Enke SA; Strauss LG; Georgi M
Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
[TBL] [Abstract][Full Text] [Related]
24. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
25. [Hereditary angioedema: changes in serum levels of C4 in response to danazol].
Egidio Fabiani J; Squiquera L; Leoni J; Simkin G; Casala A
Med Cutan Ibero Lat Am; 1987; 15(6):461-7. PubMed ID: 3323703
[TBL] [Abstract][Full Text] [Related]
26. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
27. [Hereditary angioedema: description of a sibship and review].
Matter L; Schopfer K; Voegelin HP; Fueter R
Schweiz Med Wochenschr; 1981 Aug; 111(34):1238-45. PubMed ID: 6974398
[TBL] [Abstract][Full Text] [Related]
28. [Protein chemistry of the complement system].
Nagasawa S
Tanpakushitsu Kakusan Koso; 1983 Jan; 28(1):18-44. PubMed ID: 6340167
[No Abstract] [Full Text] [Related]
29. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
Windfuhr JP; Alsenz J; Loos M
Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
[TBL] [Abstract][Full Text] [Related]
30. An investigation of the complement system in patients with periodic disease (results from 29 cases).
Hartmann L; Lego-Crescioni A; Brecy H; Ollier MP; Herreman G; Mouthon JM; Godeau P
Biomedicine; 1977 Dec; 26(6):416-24. PubMed ID: 304745
[TBL] [Abstract][Full Text] [Related]
31. Hypercomplementemia in adult patients with IgA nephropathy.
Onda K; Ohi H; Tamano M; Ohsawa I; Wakabayashi M; Horikoshi S; Fujita T; Tomino Y
J Clin Lab Anal; 2007; 21(2):77-84. PubMed ID: 17385664
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
[TBL] [Abstract][Full Text] [Related]
33. Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria.
Lackner P; Hametner C; Beer R; Burger C; Broessner G; Helbok R; Speth C; Schmutzhard E
Malar J; 2008 Oct; 7():207. PubMed ID: 18847493
[TBL] [Abstract][Full Text] [Related]
34. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
Böhm I; Speck U; Schild H
Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
[TBL] [Abstract][Full Text] [Related]
35. [Study of the relationship between complement activation and vascular endothelial damage in pregnancy induced hypertension].
Zheng Y; Chen Z; Yan J
Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):152-5. PubMed ID: 8758788
[TBL] [Abstract][Full Text] [Related]
36. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
[TBL] [Abstract][Full Text] [Related]
37. [Development of the serum levels of complement during the first year of life].
Pedraz C; Lorente F; Pedraz MJ; Salazar Villalobos V
An Esp Pediatr; 1980 Jul; 13(7):571-6. PubMed ID: 7416647
[TBL] [Abstract][Full Text] [Related]
38. Serum profiles of the regulatory complement proteins during the progression of renal damage in human glomerulonephritis.
Schena FP; Pertosa G; Stanziale P; Germinario C; Balletta M; Andreucci VE
Nephron; 1986; 44(4):272-6. PubMed ID: 2948131
[TBL] [Abstract][Full Text] [Related]
39. Complement studies in children with treated coeliac disease after gluten challenge.
Bosch C; Becker M; Rotthauwe HW; Opferkuch W
Eur J Pediatr; 1980 Aug; 134(2):145-8. PubMed ID: 6904300
[TBL] [Abstract][Full Text] [Related]
40. Changes in serum complements and their regulators in generalized myasthenia gravis.
Ozawa Y; Uzawa A; Yasuda M; Kojima Y; Oda F; Himuro K; Kawaguchi N; Kuwabara S
Eur J Neurol; 2021 Jan; 28(1):314-322. PubMed ID: 32889770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
